UK medicines regulator seeks to allay pharma industry concern, reiterating a previous promise it will be pragmatic in setting new UK drugs rules in event of no-deal Brexit

Research spending should rise to €120B in the 2021 - 2028 budget, despite shrinking EU funds post-Brexit, say MEPs

A Scottish government report lays out potential hit of divorce in a new economic forecast that first minister Nicola Sturgeon says strengthens case for UK remaining in EU single market

Viewpoint: More EU ministers and commissioners are voicing support for bigger research and innovation funding – but the political argument is a long way from won

Sector deal features 25 investments from global companies and a pledge by government to provide funding for research infrastructure and long-term capital to allow start-ups to scale

There is more than a hint of dirigisme in the first explicit national industrial strategy since the 1970s. The government says it is not about picking winners, but shaping the environment as a whole

Agency bracing itself for a potential exodus, while pharma companies fear a bottleneck in new drug approvals. Meanwhile, the bill for the removal stands at €400M

City pips Milan in tiebreaker to scoop hotly sought-after prize from London

Institutions from 22 countries demand clarification on whether and how UK will be able to participate in future EU research projects

Government looks to reassure applicants after Commission advice that UK participants on some EU research projects may have to leave after Brexit